INHA and tuberculosis: Genotype MTBDRplus can confirm resistance to two medications, such as RIF and INH, as a result of only three genes mutations, including rpoB, katG and inhA. As opposed to these two options, TB-BIOCHIP can confirm resistance to both RIF and INH resulting from mutations in four genes, including rpoB, katG, inhA and ahp.